My dad has been asked to get psma pet scan done.RP was done in jan 20. Current psa 0.20. (increased from 0.15 in 5 mnths)gleason 9& 10.detected nov.2019. positive margins.
As i am inquiring about the cost ,i came across all the hospitals asking me do you want to do the scan with contrast (dye)or just plain psma scan.last year when we did the first scan no1 asked me this,it was only one scan psma pet scan.
I am confused whats the difference between the 2. Which is better?
Written by
Prostate72
To view profiles and participate in discussions please or .
Do you have access to a Major Cancer Center? One of Excellence...? Best results always occur with those most experienced to provide the procedure or care required. The PSMA-PET scan uses an agent which binds with secretions made primarily by PCa cells. I'm unfamiliar with what they may be referencing as to "contrast", especially if proposed to be "along" with the PSMA.
But as a suggestion, when these type of questions occur, it's important to identify exactly what they're talking about. It's ok to ask "what" contrast is proposed being used specifically, by name, and if they have any literature to review on it! This will eliminate any confusion in regard to "pOtato" or "potAto"... Lol
Some people are allergic against contrast, I guess this is the reason they ask. The results will be better with contrast.
However, I would wait at least until the PSA value reaches 0.5 ng/ml. The value of 0.2 ng/ml is too low and you may only detect about 10% of the existing lesions. So it may turn out to be a waste of money.
Doc is planning for salvage radiation due to positive margins, and had a small spot on the rib but docs were not confirmed as uptake was too less,hence he has asked to get it done ..now m confused..
"Our results indicate that the vast majority of these lesions have low‐intensity uptake and are benign. Intervention to confirm this is not usually required. "
I think 0.2 is still very low. Trying to treat this spot is overtreatment. Just get another PSMA PET/CT in a year from now if the PSA value continues to rise.
Prostate72 wrote: "Doc is planning for salvage radiation due to positive margins". So I thought this is already decided. Many doctors start with sRT when the PSA level gets over 0.2 ng/ml.
The extent I mentioned below, it depends on the result of the PSMA PET/CT.
Let me elaborate in the content of the graph you just posted.
In the lowest PSA range <0.5, 38% of scans led to a positive detection.
The remaining 62%, if any spots existed, they were smaller in size than the lowest detectable size.
These 38% cases are broken down to :
Prostate bed: 6%
Pelvic Nodes (N1): 16%
The remaining 16% represent spots in multiple regions or extra-pelvic.
Consequently:
If in this sample of patients sRT to prostate bed only were administered in would had a 6/38=16% success rate.
If the pelvic Nodes were also included, the success rate would had risen to (6+16)/38=58%
Do you have any insight regarding the rest of not detected 62% as having a vastly different break down? I don't and when in doubt, I would put my money on the homogeneity of the total population against any unsubstantiated argument of the sort: "If we can't see it it must be confined in the prostate bed/pelvis".
The statistics of blind sRT giving a success rate from 40% to 60% just do me justice.
The intention of the PSMA PET/CT was to decide if you should include the pelvis in the salvage radiation. Otherwise there would be no reason for that. If no mets are detected in the pelvis you should skip radiating the pelvis and avoid its toxicities. If mets show up in the pelvis in the coming years, you can radiate these with SBRT or get a separate IMRT radiation to that area.
The positive margins provide a reason to radiate the prostate, so this should be done. But if the PSMA PET/CT does not detect any mets you can avoid extending the radiated area to the pelvis which often causes side effects.
It shows a similar break-down, though a substantially higher positive detection rate (58% for PSA<0.5). They used 18F-DCFPyL radioligand which seems to be a bit more sensitive.
This subject comes up all the time. I have posted about it an uncountable number of times. In essence it is a compromise decision. It needs to be early enough for better sRT outcome, vs later for a better PSMA PET/CT detection probability. The PSMA PET/ CT doesn't depend only on PSA. PSADT (doubling time) is equally or even more important. Your father has a high PSADT judging from the sheer fact that he reached 0.2 (PSA velocity) one year after RP. Also, things that doctors do not understand (information theory is not taught in medical schools): An absence of detection is not information void. It is the complement of a successfully detected one. This, in practice, translates to: "If anything at all, it is smaller compared to the minimum detectable size". There is a recent paper from Italy that claims a negative PSMA scan to lead to a better sRT success rate.
Your PSA is too low to detect anything. You can increase detection by starting ADT, but you may not need ADT. The contrast is for the CT scan - if you're not allergic to iodine, go ahead with it.
Sorry forgot to mention he is on pamorelin 22.5 injection every 3 mnths..we are located in mumbai india..have seen docs prefer pamorelin over lupron here
The results are better for localization of lesions when iodine contrast is used for the CT scan. If you are not allergic to iodine and your renal function is OK, the contrast could be used.
Whole pelvis radiation associated with short term hormone therapy seems to be to most effective treatment to control the cancer.
I wonder if it is related to how the patients arrived to the PSA level they had when they were studied. You could have many patients with many different PSADTs which were studied at the same PSA interval. Patients are selected to this type of study based on their PSA regardless of their PSADT.
PSADT and PSA velocity are two different metrics of the exact samething. The time sequence of the person's PSA. I have in my computer some 20 papers on the subject. The second link that you posted, the one from Heidelberg, is my favourite. I had missed the first one, so started reading it. Passing over the offending paragraph, I just stopped. If they are that clumsy to write such things, then they are not serious enough to spend time for reading any further, I thought and didn't go any further.
Has your farther had his prostate out? With PSA readings of 0.15 & 0.20 these indicate he’s had treatment done. But then you mention his Gleason scores which indicate he still has his prostate? Which is correct?
Yes rp in jan 2020, dec 19 took pamorelin 22.5 injections which he takes every 3 mnths psa was stable at 0.15 till August November 0.19 ,jan 21 .. psa 0.20
Sorry there are many conflicting opinions here but I must add what I know. PSA level of detection for either PSMA scan isotope (Ga68 or DCFPyL) is 0.20. That is the cutoff for UCLA in their protocols. It is not futile. My PSA was 0.23 when I found 2 cancerous lymph nodes in my pelvis by this scan that were subsequently irradiation.
No other “contrast is used in PSMA PET scans other than the isotope and binding ligand that causes it to bind to the PSMA molecule on the surface of cancer cells 68-Ga-PSMA-I&T and other variants).
3. The question about contrast was just a routine one for those doing intakes and are not applicable. So just answer no if you are not allergic to iodine, etc. 4. The standard radiation field now recommended for salvage radiation therapy includes the pelvic lymph nodes as well as the prostate bed ( extended field per RTOG guidelines).
So my personal suggestions is: go for the PSMA scan now to see what it can show. If there are PSMA avid lesions outside of the pelvis already then you are already metastatic and the salvage RT would be futile. If there are no such lesions outside the pelvis then I would certainly go for salvage RT including the PLN fields. One year or up to two years of ADT of adjuvant (accompanying) has been shown to improve chances of long term success. So this should be used. These are my own opinions from research of this and my own experience. Good luck to you sir.
The G68-PSMA-PET is superior to the F18 agent... I suggest those who are interested to find and actually read the data on the studies performed. They used more agent and allowed it to dwell longer for additional uptake on the F18 scans. F18 has been pushed because it's more durable and can travel, allowing remote facilities to offer it. I don't recall the particulars, but that's what I remember between the two. Other relavent data has already been posted as to it's efficacy and sensitivity (G68).
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.